CDK5 and neoplasm: Experimental data demonstrate that LIMK1 and CDK5 synergistically facilitate cancer metastasis through a mechanism dependent on phosphorylation and co-targeting LIMK1 and CDK5 significantly suppresses tumor metastasis [39].